Impaired Deoxyribonuclease Activity in Monoglandular and Polyglandular Autoimmunity

Abstract

Objective: The enzyme desoxyribonuclease (DNase) degrades DNA during early apoptosis. Impaired DNase activity might increase susceptibility to autoimmune diseases. This study examined for the first time DNase activity in endocrine autoimmunity.

Methods: Included were 112 patients with monoglandular (MGA) or polyglandular autoimmunity (PGA), their 93 healthy relatives, and 41 healthy controls. Serum DNase activity was quantified with a solid phase enzyme immunometric assay comprising degradation of the specific immobilized DNase substrate, formation of enzyme conjugate complexes using horseradish peroxidase conjugate solution, and enzymatic colour reaction.

Results: The Bland-Altman plot of the interassay differences suggested good reproducibility (n=96). Compared to healthy controls (median 9.8, range 5.2-16.7 ng/ml), DNase activity was markedly lowered in patients with endocrine autoimmunity (5.8, 2.6-26.2 ng/ml; p<0.0001). Corresponding values in the following MGA, PGA, and relatives groups were 4.8 (2.8-19.0) ng/ml, 7.9 (2.6-26.2) ng/ml, and 8.4 (1.5-19.0) ng/ml, respectively. When MGA patients were splitted up by disease, patients with type 1 diabetes had the lowest DNase activity (3.6, 3.2-3.9 ng/ml) which positively correlated with HbA1c in females (r=0.486, p=0.041). Pathological reduction of DNase activity (below 5 ng/ml) was noted in 54%, 31%, 24%, and 0% of MGA, PGA, relatives, and controls, respectively. Anti-ds-DNA and anti-nucleosome antibodies were negative in the patients with MGA and PGA.

Conclusions: These findings indicate the potential relevance of DNase activity in patients with monoglandular and polyglandular autoimmunity and their clinically healthy relatives. The impaired DNase activity might reduce removal of circulating self- or pathogen-derived DNA thereby favoring autoimmune mechanisms by Toll-like receptor 9 co-activation.

DNase - monoglandular and polyglandular autoimmunity - reproducibility

References

• 1 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement.  Lancet. 1986;  1 307-310
• 2 Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells.  Biochim Biophys Acta. 2001;  1518 157-161
• 3 Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes - immunogenetics and longterm follow-up.  J Clin Endocrinol Metab. 2003;  88 2983-2992
• 4 Dittmar M, Kahaly GJ. Genetics of autoimmune hypoparathyroidism.  Clin Cases Mineral Bone Metab. 2004;  1 113-116
• 5 Dittmar M, Kahaly GJ. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity.  Thyroid. 2005;  15 239-250
• 6 Funakoshi A, Wakasugi H, Ibayashi H. Clinical investigation of serum deoxyribonuclease II. Clinical studies of serum deoxyribonuclease activity in pancreatic disease.  Gastroenterol Jap. 1979;  14 436-440
• 7 Iida R, Yasuda T, Aoyama M, Tsubota E, Kobayashi M, Yuasa I, Matsuki T, Kishi K. The fifth allele of the human deoxyribonuclease I (DNase I) polymorphism.  Electrophoresis. 1997;  18 1936-1939
• 8 Lachmann PJ. The in vivo destruction of antigen - a tool for probing and modulating an autoimmune response.  Clin Exp Immunol. 1996;  106 187-189
• 9 Lazarides E, Lindberg U. Actin is the naturally occurring inhibitor of deoxyribonuclease I.  Proc Natl Acad Sci USA. 1974;  71 4742-4746
• 10 Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.  Nature. 2002;  416 603-607
• 11 Napirei M, Wulf S, Mannherz HG. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system.  Arthrit Rheum. 2004;  50 1873-1883
• 12 Oliveri M, Daga A, Cantoni C, Lunardi C, Millo R, Puccetti A. DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.  Eur J Immunol. 2001;  31 743-751
• 13 Oliveri M, Daga A, Lunardi C, Navone R, Millo R, Puccetti A. DNase I behaves as a transcription factor which modulates Fas expression in human cells.  Eur J Immunol. 2004;  34 273-279
• 14 Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll.  Proc Natl Acad Sci USA. 1998;  95 588-593
• 15 Segal BM, Chang JT, Shevach EM. CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo.  J Immunol. 2000;  164 5683-5688
• 16 Thomas JW, Kendall PL, Mitchell HG. The natural autoantibody repertoire of nonobese diabetic mice is highly active.  J Immunol. 2002;  169 6617-6624
• 17 Wilbe A, O'Connor TP, Lu ML, Karimi A, Schneider MC. Dnase1l3 deficiency in lupus-prone MRL and NZB/W F1 mice.  Clin Exp Immunol. 2003;  134 46-52
• 18 Yasuda T, Nadano D, Takeshita H, Tenjo E, Kishi K. Molecular analysis of the third allele of human deoxyribonuclease I polymorphism.  Ann Hum Genet. 1995;  59 139-147
• 19 Yasuda T, Takeshita H, Iida R, Kogure S, Kishi K. A new allele, DNASE1^*6, of human deoxyribonuclease I polymorphism encodes an Arg to Cys substitution responsible for its instability.  Biochem Biophys Res Comm. 1999;  260 280-283
• 20 Yasumoto K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, Kuroda Y. Mutation of DNASE1 in people with systemic lupus erythematosus.  Nat Genet. 2001;  28 313-314

Correspondence